Sponsor:
University Hospitals Cleveland Medical Center
Code:
NCT07091123
Conditions
Persistent Spinal Pain Syndrome
Eligibility Criteria
Sex: All
Age: 30+
Healthy Volunteers: Not accepted
Interventions
Pain pump
Bupivacain 0.625%/Fentanyl 2mcg/ml
Spinal Cord Stimulator (SCS)
Brief summary:
Conditions
Persistent Spinal Pain Syndrome
Study ID
NCT07091123
Start date
Oct 13, 2025
Status verified date
Jan, 2026
Completion date
Aug 11, 2027
Anticipated
Primary completion date
Aug 11, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 30+
Healthy Volunteers: Not accepted
Enrollment
36 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Treatment
Arms
active comparator: Group A
active comparator: Group B
Interventions
Pain pump
Bupivacain 0.625%/Fentanyl 2mcg/ml
Spinal Cord Stimulator (SCS)
Primary outcome measure
Central contacts
Locations
University Hospitals Cleveland Medical Center
Recruiting
Cleveland, Ohio, United States, 44106
Sponsor
University Hospitals Cleveland Medical Center
Last update posted
Feb 3, 2026
Last verified
Jan, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University Hospitals Cleveland Medical Center on 2026-02-03.